Purification of proteins and vaccines is vital to biotechnology. Innovation in this industry has lagged, leading to manufacturing bottlenecks. This is especially apparent in antibody production and rapid response pandemic manufacturing. Chromatan has developed Continuous Countercurrent Tangential Chromatography (CCTC) - a new column-free process that will revolutionize the industry by providing a scalable, disposable and cost saving (65%) alternative to existing purification technologies